World Business NewsA round up of the latest news for those doing business internationally
FDA orders GlaxoSmithKline to review manufacturing worldwide
Zone(s): USA, UK ¦ Sector(s): Manufacturing
[24 June 2014, The Guardian] By Julia Kollewe – Britain’s biggest drugmaker warned by US watchdog over flu vaccine production at Canadian subsidiary: The US Food and Drug Administration has ordered GlaxoSmithKline to review its manufacturing operations globally after finding that its Canadian subsidiary violated quality requirements during the manufacture of its flu vaccine FluLaval.
It is another serious blow to Britain’s biggest drugmaker, already reeling from corruption allegations in Poland, Iraq, Jordan, Lebanon and China, and facing a criminal investigation by the UK’s Serious Fraud Office into its sales practices. It also recently paid out £63m to settle US marketing allegations. Earlier this week GSK had to apologise for the pitch adopted by a marketing firm working for the FTSE 100 company to recruit unpaid interns for clinical trials in the UK.